Top View
- Memantine Upregulates BDNF and Prevents Dopamine Deficits in SIV-Infected Macaques: a Novel Pharmacological Action of Memantine
- United States Patent (19) 11 Patent Number: 5,925,634 Olney (45) Date of Patent: *Jul
- The Behavioral Pharmacology of Hallucinogens
- In Search of a New Pharmacological Treatment for Drug and Alcohol Addiction: N-Methyl-D-Aspartate (NMDA) Antagonists
- “Herbal Seizures” – Atypical Symptoms After Ibogaine Intoxication: a Case
- New Insights Into the Biology of Schizophrenia Through the Mechanism of Action of Clozapine
- Faa-Meds.Pdf
- Medications.Pdf
- Mechanisms Underlying Differential Effectiveness of Memantine and Ketamine in Rapid Antidepressant Responses
- Potentiation of General Anaesthetic Activity of Ketamine by Memantine
- High-Dose Donepezil Or Memantine: Next Step for Alzheimer’S Disease?
- Mechanisms of Nmda Receptor Inhibition by Memantine and Ketamine
- Parkinsons Disease
- Rotigotine Transdermal Patch ESCA: for the Treatment of Parkinson's Disease
- Effects of Nitrous Oxide on Dopamine Release in the Rat Nucleus Accumbens and Expectation of Reward
- The Ketamine Antidepressant Story: New Insights
- Comparison of the Effects of Ketamine and Memantine on Prolactin And
- Pharmacodynamics of Memantine: an Update G
- WO 2016/145193 Al 15 September 2016 (15.09.2016) P O P C T
- Biol. Pharm. Bull. 32(5): 850-855 (2009)
- Metabolic Stability and Pharmacokinetics in Lead Optimization of Potential Anti-Psychostimulant Pharmacotherapies
- A Treatment Guide to Parkinson's Disease
- (12) United States Patent (10) Patent No.: US 9,051,343 B2 Gless, Jr
- 2021 Home Delivery and Retail 90-Day Supply List
- Rotigotine (Neupro) National Drug Monograph March 2013 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
- NAMENDA XR Capsules Safely and Effectively
- Substance Abuse in the Workplaces of Our Bodies and Mind
- The Serotonin Syndrome: from Molecular Mechanisms to Clinical Practice
- A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
- Memantine Increases NMDA Receptor Level in the Prefrontal Cortex but Fails to Reverse Apomorphine-Induced Conditioned Place Preference in Rats
- Customs and Border Protection Medication Formulary
- Ibogaine Offers an Alternative Approach for Treating Opiate Addiction
- Derivatives of Piperazines As Potential Therapeutic Agents for Alzheimer's
- Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization
- Nitrous Oxide for Treatment-Resistant Major Depression a Proof-Of
- Transdermal Therapeutic Systems for Memantine Delivery. Comparison Of
- The Effect of Memantine on Behavioural Sensitisation to Methamphetamine in Mice
- The Ins and Outs of PD Meds Johanna Hartlein, APRN, MSN Family Nurse Practitoner and Great Hugger Washington University School of Medicine Words of Caution
- APOMORPHINE Injection
- The Neurotoxicity of Nitrous Oxide: the Facts and “Putative” Mechanisms
- Cabergoline Neurology Shared Care Guideline
- Memantine Increases NMDA Receptor Level In
- Neuroprotective Properties of Memantine in Different in Vitro and in Vivo Models of Excitotoxicity
- Reinstatement of Morphine-Conditioned Reward Is Blocked by Memantine
- Effects of Verapamil, Cinnarizine and Memantine on Maximal Electroshock, Picrotoxin, and Pilocarpine-Induced Seizure Models in Albino Mice
- Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
- INFORMATION for the USER Memantine
- An Experimental Study to Evaluate the Effect of Memantine in Animal Models Of
- August Pharmacy Newsletter
- Parkinsons Disease